Vlispxpert's Underground

[matt24d]

VBIV just needs some patience. I too have added shares. The share direction does not change the fact their HEP B drug had great results. Also their cancer drug has had good results and they just basically got their COVID funded for awhile. The latest Hep B drug on the market did like 1 billion in sales last year. VBIV's drug had better results in the lab. Even if they get 10-15% of the market that puts them in the cash big time. Sometimes you have to let the story come together for the bigger pay out and that is especially in biotech.